USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: PHOENIX BIOSYSTEM, INC.
City: PLEASANTON
State: CA
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (925) 249-1125

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $3,309,956.00 14
SBIR Phase II $1,991,333.00 3

Award List:

Nano Liter Scale Blood Sampling and Analysis System

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: DOE
Principal Investigator: Kumar Subramanian
Award Amount: $100,000.00
Abstract:
70156 Neonatal medicine continues to make rapid progress. Babies born at 26 weeks of gestation now have a better than even chance of survival, a remarkable improvement compared to even a decade ago. While the intensive care of sick newborns has improved, the pain and potentially adverse… More

MEMS BASED CONTINUOUS ALCOHOL MONITORING DEVICE

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kumar Subramanian
Award Amount: $399,851.00
Abstract:
DESCRIPTION (provided by applicant): This two year Phase I project will combine the electrochemical biosensor technology with the unique silicon microneedle based ex-vivo monitoring technology, to produce low cost MEMS (MicroElectroMechanicalSystems) for continuous monitoring of blood alcohol… More

Painless Nanoliter Glucose Assay For Diabetics

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael F. Tomasco
Award Amount: $257,700.00
Abstract:
(Revised) Description: Phoenix Biosystem is developing enabling technologies for continuous monitoring of analytes by adapting technology from the University of California. While a great many innovative technologies have been proposed, only a fraction are in advanced stages of development. Blood… More

MEMS Based Sternal Skin Conductance Monitoring

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kumar Subramanian
Award Amount: $250,000.00
Abstract:
DESCRIPTION (provided by applicant): Phoenix Biosystem proposes to develop a micro sensor for the sternal skin conductance measurement that can be optimized into a small, easy to use diagnostic device. The specific aims are: a) Identify characteristics of existing sternal skin conductance monitors… More

MEMS Based Continuous Alcohol Monitoring Device

Award Year / Program / Phase: 2006 / SBIR / Phase II
Agency: HHS
Principal Investigator: Kumar Subramanian
Award Amount: $812,212.00
Abstract:
DESCRIPTION (provided by applicant): Phoenix Biosystem is developing enabling technologies for continuous monitoring of analytes. While a great many innovative technologies have been proposed, only a fraction are in advanced stages of development. Blood gas, electrolyte and glucose values are a… More

Real Time Monitoring of Environmental Exposure To Pesticides

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kumar Subramanian
Award Amount: $538,011.00
Abstract:
DESCRIPTION (provided by applicant) Phoenix Biosystem intends to leverage the in-house expertise in sensors, microfluidics, and microelectronics to design, develop and validate novel, battery powered portable measurement technologies which, by the e nd of the Phase II funding period, will… More

SBIR Phase I: Label Free Nucleic Acid Assays for POC Diagnostics

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: NSF
Principal Investigator: Kumar Subramanian, MS
Award Amount: $99,745.00
Abstract:
This Small Business Innovation Research (SBIR) Phase I project proposes to develop a Label Free Nucleic Acid Assay for Point-Of-Care (POC) Diagnostics especially for Sexually Transmitted Infections (STI). The broader impacts of this research are to enable effective diagnosis and treatment of… More

Home-Based Lithium Level Testing for Bipolar Patients

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kumar Subramanian
Award Amount: $183,558.00

Hand-held Device for Multiplex Analysis of Proteins in Blood

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency / Branch: DOD / ARMY
Principal Investigator: Kumar Subramanian, President
Award Amount: $69,703.00
Abstract:
Phoenix Biosystem proposes to develop a hand-held, point-of-care (POC) analyzer that would be a unified device capable of collecting blood samples from personnel in a painless, minimally invasive manner, performing necessary sample processing, and providing results for specific biomarkers within 10… More

Develop Field-usable Diagnostic Devices for the Specific Detection of Leishmania Major and L. Infantum in Sand Flies

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency / Branch: DOD / OSD
Principal Investigator: Kumar Subramanian, Principal Investigator
Award Amount: $99,368.00
Abstract:
Leishmaniasis has been of concern to U.S. military personnel in the 20th century and has re-emerged in importance because of recent deployments to the Middle East. Although leishmaniasis is not considered a disease of strategic military signi_cance, it may pose a significant threat to mission… More

Hand-held Device for Multiplex Analysis of Proteins in Blood

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: DOD
Principal Investigator: Kumar Subramanian, Principal Investigator – (925) 998-5075
Award Amount: $728,626.00
Abstract:
Phoenix Biosystem proposes to develop a microfluidics based, multiplexed, Point Of Care (POC) assay technology platform for protein measurement in whole blood/plasma. Our proposed technology platform will consist of a hand-held meter and a disposable microfluidic cartridge with a multiplexed array… More

SBIR Phase II:Label Free Nucleic Acid Assays for POC Diagnostics

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: NSF
Principal Investigator: Kumar Subramanian
Award Amount: $450,495.00
Abstract:
This Small Business Innovation Research (SBIR) Phase II project proposes to develop a for point-of-care (POC) nucleic acid assay for STD (sexually transmitted diseases) diagnostics using Electrochemical Impedance Spectroscopy (EIS). Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC)… More

Improved methodologies to measure novel alcohol biomarkers in whole blood

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kumar Subramanian – 925-998-5075
Award Amount: $210,484.00
Abstract:
DESCRIPTION (provided by applicant): Phosphatidylethanol (PEth) is a phospholipid formed only in the presence of ethanol via the action of phospholipase D. It has been measured in whole blood and proposed as a marker of ethanol abuse due to its high specificity and low degradation rate. The mean… More

Multiplexed Biomarkers for staging Alzheimer???s Disease

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kumar Subramanian – 925-998-5075
Award Amount: $170,833.00
Abstract:
DESCRIPTION (provided by applicant): With the growing prevalence of AD, the ability to accurately and reliably diagnose AD in its earliest stages has become a public health priority. Clinicopathological studies suggest that AD pathology begins 10-15 yearsbefore the resulting cognitive impairment… More

POINT OF CARE DIAGNOSTICS FOR URINARY TRACT INFECTION

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kumar Subramanian – 925-998-5075
Award Amount: $294,871.00
Abstract:
DESCRIPTION (provided by applicant): Urinary tract infection (UTI) is an extremely common condition that occurs in both males and females of all ages and in children. UTI is the most common urological disease in the United States and the second most commonbacterial infection of any organ system.… More

High throughput Point-of-Care assays for diabetes auto-antibody detection

Award Year / Program / Phase: 2012 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kumar Subramanian – 925-998-5075
Award Amount: $439,584.00
Abstract:
DESCRIPTION (provided by applicant): With the growing prevalence of diabetes, the ability to accurately and reliably diagnose diabetes in its earliest stages has become a public health priority. Early identification of T1D risk and the onset of autoimmunity provide the basis for a variety of major… More

Enhancing protective antibody responses for a GM-CSF adjuvanted HIV vaccine

Award Year / Program / Phase: 2013 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kumar Subramanian – 925-998-5075
Award Amount: $196,248.00
Abstract:
DESCRIPTION (provided by applicant): The success of HIV antibody tests in narrowing the window period of HIV diagnosis has been notable. However, immunoassays designed to detect antibody alone will not be able to identify individuals with acute infection who have not yet begun to produce… More